Laboratorios Richmond SACIF operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Laboratorios Richmond SACIF with three other pharmaceutical manufacturers in Latin America: Ouro Fino Saude Animal Participacoes SA of BRAZIL (2019 sales of 619.59 million Brazilian Reals [US$117.30 million] of which 75% was Production Animals), Fleury SA of BRAZIL (2.91 billion Brazilian Reals [US$549.99 million] of which 84% was Diagnostic Medicine), and Instituto Hermes Pardini SA which is also based in BRAZIL (1.35 billion Brazilian Reals [US$256.27 million] of which 100% was auxiliary diagnostic support services).

Sales Analysis. During the year ended December of 2019, sales at Laboratorios Richmond SACIF were 3.90 billion Argentinian Pesos (US$45.42 million). This is an increase of 114.4% versus 2018, when the company's sales were 1.82 billion Argentinian Pesos . This was the fifth consecutive year of sales increases at Laboratorios Richmond SACIF (and since 2014, sales have increased a total of 1,040%). Sales of Public Market saw an increase of 184.3% in 2019, from 386.21 million Argentinian Pesos to 1.10 billion Argentinian Pesos .